Peer-reviewedCC BYJAAD case reports
Cutaneous B-cell lymphoid hyperplasia successfully treated with oral abrocitinib: A case report.
4 affiliations
- 1University of Arizona, College of Medicine, Phoenix, Arizona.
- 2HonorHealth, Dermatology Residency, Scottsdale, Arizona.
- 3US Dermatology Partners, Phoenix, Arizona.
- 4Medical Dermatology Specialists, Phoenix, Arizona.
Related
- Clinicopathological Evaluation of Terminal Ileal Nodular Lymphoid Hyperplasia in Adults: A Single-Center Experience
- 1190 Spatial and phenotypic characterization of tertiary lymphoid structures and immune organization in cutaneous squamous cell carcinoma using multiplex immunofluorescence
- 974 Integrated multimodal profiling reveals conserved type II interferon signalling, ectopic lymphoid structure formation, and actionable inflammatory endotypes in cutaneous immune-related adverse events
- A Case of Neurohistoplasmosis Successfully Treated With Single High-Dose Liposomal Amphotericin B
- Osimertinib induced lichenoid dermatitis successfully treated with acitretin.
BibTeX
@article{sparling2026cutaneous,
title = {{Cutaneous B-cell lymphoid hyperplasia successfully treated with oral abrocitinib: A case report.}},
author = {Kennedy Sparling and Daniella M Allevato and David Glembocki and Christina Harview},
journal = {JAAD case reports},
year = {2026},
month = sep,
doi = {10.1016/j.jdcr.2026.09.019},
url = {https://europepmc.org/article/MED/42997552},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cutaneous B-cell lymphoid hyperplasia successfully treated with oral abrocitinib: A case report.
AU - Kennedy Sparling
AU - Daniella M Allevato
AU - David Glembocki
AU - Christina Harview
PY - 2026
DA - 2026/09/20
JO - JAAD case reports
DO - 10.1016/j.jdcr.2026.09.019
UR - https://europepmc.org/article/MED/42997552
SN - 2352-5126
ER -